NASDAQ · CHRS

Coherus Oncology, Inc.

Closing price · Nov 13, 2026 $0.5255

Latest quarter · ended Sep 30, 2026

Cash got weaker, but sales grew

descriptionFiled Nov 9, 2026
Revenue growthSlower
+23.4%
Quarter ended Dec 31, 2024: −91.6% sales vs. a year beforeQuarter ended Mar 31, 2025: +229.2% sales vs. a year beforeQuarter ended Jun 30, 2025: −0.4% sales vs. a year beforeQuarter ended Sep 30, 2025: +91.2% sales vs. a year beforeQuarter ended Dec 31, 2025: +64.9% sales vs. a year beforeQuarter ended Mar 31, 2026: +62.0% sales vs. a year beforeQuarter ended Jun 30, 2026: +39.5% sales vs. a year beforeQuarter ended Sep 30, 2026: +23.4% sales vs. a year before
Dec '24Sep '26
$14.3M vs. $11.6M a year ago
Cash from operationsBetter
−$34M
Quarter ended Dec 31, 2024: $28.6M cash from operationsQuarter ended Mar 31, 2025: −$25.8M cash from operationsQuarter ended Jun 30, 2025: −$46.6M cash from operationsQuarter ended Sep 30, 2025: −$46.3M cash from operationsQuarter ended Dec 31, 2025: −$19.7M cash from operationsQuarter ended Mar 31, 2026: −$57.9M cash from operationsQuarter ended Jun 30, 2026: −$62.1M cash from operationsQuarter ended Sep 30, 2026: −$34M cash from operations
Dec '24Sep '26
vs. −$46.3M a year ago
Share countDiluting
+27.9%
Quarter ended Dec 31, 2024: 115.9M sharesQuarter ended Mar 31, 2025: 115.93M sharesQuarter ended Jun 30, 2025: 116.23M sharesQuarter ended Sep 30, 2025: 120.87M sharesQuarter ended Dec 31, 2025: 149.89M sharesQuarter ended Mar 31, 2026: 154.25M sharesQuarter ended Jun 30, 2026: 154.5M sharesQuarter ended Sep 30, 2026: 154.54M shares
Dec '24Sep '26
154.54M shares vs. 120.87M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −17
  • account_balance
    1 fund bought, 2 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

150 funds report owning CHRS, down from 158

Holdings as of Jun 30, 2026
New14
Added60
Held43
Trimmed33
Sold out22

Last quarter

Who bought and who sold

Apr–Jun 2026
Timothy G. Youngquist 2020 Irrevocable Trust
+6%
Tang Capital Management LLC
Sold
Propel Bio Management, LLC
Sold

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

No open-market buys or sales by officers or directors in the last 12 months. Hidden: 9 stock grants, 2 tax withholdings. Press All filings to see them.

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovShares withheld for tax · Jan 20 · $18.4KShares withheld for tax · Jan 20 · $2.66KStock grant · Jan 22 · 112,500 shStock grant · Jan 23 · 375,000 shStock grant · Jun 5 · 210,000 sh · 7 people
CEOCFOOther officersDirectorsJunJulAugSepOctNovStock grant · Jun 5 · 210,000 sh · 7 people

Last 6 months. A wider screen shows 12.

Showing 0 real trades. Hidden: 9 stock grants, 2 tax withholdings. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Big bets

Funds with a big share of their money in CHRS

As of Jun 30, 2026
FundOf fundOwnsValueChange
Timothy G. Youngquist 2020 Irrevocable Trust4%8.4%$18.3M+6%

Funds that hold 150 stocks or fewer, where this stock is 3% or more of what they reported. "Of fund" is its share of the fund's 13F value.

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist